NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
LOTUS EYE CARE HOSPITAL LTD. (BSE: 532998)
532998 Technical Analysis
4
As on 24th Apr 2024 532998 SHARE Price closed @ 61.60 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 80.75 & Sell for SHORT-TERM with Stoploss of 64.59 we also expect STOCK to react on Following IMPORTANT LEVELS. |
532998SHARE Price
Open | 59.98 | Change | Price | % |
High | 61.95 | 1 Day | 2.41 | 4.07 |
Low | 59.98 | 1 Week | 0.83 | 1.37 |
Close | 61.60 | 1 Month | 3.72 | 6.43 |
Volume | 2449 | 1 Year | 0.02 | 0.03 |
52 Week High 110.90 | 52 Week Low 44.10 |
BSE INDIA Most Active Stocks
532822 | 13.09 | -9.03% |
512149 | 0.93 | 2.20% |
532775 | 1.74 | 0.58% |
532648 | 25.47 | -0.74% |
517001 | 0.09 | 12.50% |
533122 | 8.83 | -0.34% |
505523 | 0.90 | -3.23% |
511389 | 7.25 | -2.42% |
534690 | 7.65 | 4.79% |
532407 | 168.18 | 4.84% |
BSE INDIA Top Gainers Stocks
BSE INDIA Top Losers Stocks
532998 Daily Charts |
532998 Intraday Charts |
Whats New @ Bazaartrend |
532998 Free Analysis |
|
532998 Important Levels Intraday
RESISTANCE | 65.40 |
RESISTANCE | 64.18 |
RESISTANCE | 63.43 |
RESISTANCE | 62.67 |
SUPPORT | 60.53 |
SUPPORT | 59.77 |
SUPPORT | 59.02 |
SUPPORT | 57.80 |
532998 Target April 2024
4th UP Target | 119.4 |
3rd UP Target | 99.23 |
2nd UP Target | 86.76 |
1st UP Target | 74.29 |
1st DOWN Target | 38.71 |
2nd DOWN Target | 26.24 |
3rd DOWN Target | 13.77 |
4th DOWN Target | -6.4 |
532998 Weekly Target
4th UP Target | 67.63 |
3rd UP Target | 65.34 |
2nd UP Target | 63.93 |
1st UP Target | 62.52 |
1st DOWN Target | 58.48 |
2nd DOWN Target | 57.07 |
3rd DOWN Target | 55.66 |
4th DOWN Target | 53.37 |
532998 Target2024
4th UP Target | 188.56 |
3rd UP Target | 154.82 |
2nd UP Target | 133.96 |
1st UP Target | 113.11 |
1st DOWN Target | 53.59 |
2nd DOWN Target | 32.74 |
3rd DOWN Target | 11.88 |
4th DOWN Target | -21.86 |
LOTUS EYE CARE HOSPITAL LTD. ( BSE INDIA Symbol : 532998 )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
532998 Other Details
Segment | EQ | |
Market Capital | 562540672.00 | |
Sector | Other | |
Industry | Other | |
Offical website | > echo $website ; ?> |
532998 Address
532998 Latest News
532998 Business Profile
Lotus Eye Hospital and Institute Limited, an eye hospital, provides eye care and related services in India. It provides services in the areas of refractive surgery, glaucoma, retina and uvea, cornea, paediatric and squint, orbit and oculoplasty, and neuro ophthalmology. The company also offers cataracts and intraocular lenses, as well as operates an eye bank. In addition, it provides ophthalmic fellowship training courses in cornea, glaucoma, retina, and anterior segments, as well as DNB teaching and training services. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was incorporated in 1997 and is based in Coimbatore, India. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service